Daan P. Hurkmans

High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients

Luca Cantini, Federica Pecci, Daan P. Hurkmans et al. · European Journal of Cancer · 2020 · 113 citations · Full text

Medicine, Oncology, Pharmacology +15

Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients

Daan P. Hurkmans, Merian E. Kuipers, Ronald van Marion et al. · Cancer Immunology Immunotherapy · 2020 · 102 citations · Full text

Life Sciences, Immunology, Oncology +17

Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients

Edwin A. Basak, Jan W.M. van der Meer, Daan P. Hurkmans et al. · Thyroid · 2020 · 88 citations

Life Sciences, Immunology, Oncology +17

A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients

Daan P. Hurkmans, Edwin A. Basak, Tanja C. van Dijk et al. · Journal for ImmunoTherapy of Cancer · 2019 · 82 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Correlation between nivolumab exposure and treatment outcomes in non–small-cell lung cancer

Edwin A. Basak, Stijn L.W. Koolen, Daan P. Hurkmans et al. · European Journal of Cancer · 2019 · 72 citations

Pharmacy, Oncology, Pharmacotherapy +13